BIO CEO & Investor Conference Has Grown in Size and Offered Insight on Industry Mood

OneMedPlace just returned from the 14th annual BIO CEO & Invester Conference, hosted by the Biotechnology Industry Organization (BIO) at the Waldorf=Astoria Hotel in New York City, February 13-14, 2012. This is the largest investor conference focused on established and emerging publicly traded biotech companies. Attendance has grown; 1200 industry leaders, 140 presenting companies resulting in 1300 one on one meetings.

“The BIO CEO & Investor Conference synthesized the overall mood within the industry of momentum and progress with recent approvals and increased M&A activity, and optimism for the year ahead,” said Alan Eisenberg, executive vice president of Emerging Companies and Business Development at BIO.

According to BIO’s statistics, “a majority of investors (56%) still think now is a good time to invest, specifically with early stage companies and those focused on autoimmune disease and oncology. Furthermore,  investors expect a marked increase in biotech IPO’s in 2012”.

The event appeared to be highly successful and the networking receptions provided  great tastings and cocktails leading to more “impromptu” one on one meetings.

For more information about the conference and BIO please visit their website

Mark your calendar for these upcoming BIO events:

BIO IP Counsels Committee Conference
April 16 – 18, 2012
Austin, TX

World Congress on Industrial Biotechnology & Bioprocessing
April 29-May 2, 2012
Orlando, FL

2012 BIO International Convention
June 18-21, 2012
Boston, MA

BIO Business Forum
June 18 – 21, 2012
Boston, MA

The comments are closed.